Fourier’s Zen Koh Recognised as Top 10 Inspiring Healthcare Entrepreneurs to Watch In 2023

Singapore, 22 February – Fourier Intelligence is excited to announce that its Co-Founder and Global CEO, Zen Koh, has been recognised as one of the Top 10 Inspiring Healthcare Entrepreneurs to Watch in 2023 by Entrepreneur Asia Pacific. This prestigious honour is a testament to Zen’s exceptional leadership, vision, and contributions to the healthcare industry. We at Fourier Intelligence are proud to have Zen at the helm and congratulate him on this well-deserved recognition.

Fourier Intelligence, a leading provider of innovative rehabilitation technology solutions, has announced that Zen Koh, a highly experienced and respected industry veteran, has been overseeing the company’s neurorehabilitation robotics program since he joined the team in 2018. Before joining Fourier Intelligence, Zen spent over a decade working with a Swiss-based company, where he developed extensive expertise in brain injuries and neuro-disorders.

The prestigious Top 10 Inspiring Healthcare Entrepreneurs to Watch in 2023 award is bestowed upon entrepreneurs who display excellence and innovative qualities in their field. This recognition showcases Fourier Intelligence’s commitment to improving patient care and its dedication to revolutionising the healthcare industry with its cutting-edge technology. Fourier Intelligence has achieved significant success quickly, and this recent accolade further confirms that the group understands what the healthcare industry requires in the unique post-pandemic market.

Zen Koh, Fourier Intelligence

“This prestigious honour deeply humbles me. It is a testament to Fourier Intelligence’s commitment to advancing the healthcare industry through collaboration with clinical research and technology development partners. This recognition further reinforces our dedication to achieving our vision of creating a more consolidated and standardised healthcare industry that benefits our industry and the wider community. We look forward to continuing our journey towards this goal with our valued partners.”

As the Co-Founder and Global CEO of Fourier Intelligence, Zen has been instrumental in ensuring that the company’s breakthrough technology meets the needs of patients across all age groups. His vast experience and in-depth industry knowledge have been invaluable in guiding the company towards achieving its mission of revolutionising the healthcare industry with innovative rehabilitation technology solutions.

Under Zen’s leadership, Fourier Intelligence has made significant strides in the field of neurorehabilitation robotics, and the company is well-positioned to continue its success in the future. Fourier Intelligence remains committed to delivering the highest quality patient care through its state-of-the-art technology. Zen’s contributions to the company’s success have been instrumental in achieving this goal.

Upon being recognised as one of Entrepreneur Asia Pacific’s Top 10 Inspiring Healthcare Entrepreneurs to Watch in 2023, Zen Koh, Co-Founder and Global CEO of Fourier Intelligence, expressed his gratitude and dedication to the company’s mission. When asked about this accomplishment, he remarked, “Fourier is dedicated to providing cutting-edge, high-quality technologies to advance clinical rehabilitation to provide more comprehensive and user-centred solutions. It’s an honour to be recognised alongside some of today’s most successful entrepreneurs.”

Based in Singapore, Zen holds multiple leadership positions, including the incoming president of the International Industry Society for Advanced Rehabilitation Technology (IISART), General Chair for RehabWeek 2023, co-founder and Executive Director of the Swiss-based MotusAcademy Association, and Managing Editor of the Journal of Rehabilitation Methods and Technologies (JRMT).

Zen’s extensive experience in the industry has been significant in driving Fourier Intelligence’s growth and success. His diverse skillset and leadership positions highlight his commitment to advancing the rehabilitation technology field and improving patient care.

As a Co-Founder and Global CEO of Fourier Intelligence, Zen’s unwavering dedication to delivering high-quality, innovative rehabilitation technology has led to the company’s reputation as a leader in the field. Zen’s continued involvement in industry organisations and initiatives further cements his position as a respected thought leader and advocate for patient-centred care.

Fourier Intelligence remains committed to providing high-quality patient care through innovative rehabilitation technology solutions. Zen’s continued leadership and involvement in industry organisations and initiatives will be critical to the company’s continued growth and success.

About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

For investor and media inquiries, please contact:

Sarah LIM
Assistant Director, Support Services
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fftai.com

Fourier Intelligence and John Hopkins Aramco Healthcare Signs MOU to Advance AI in Physical Rehabilitation

Riyadh, Saudi Arabia, 21 February 2023 – Fourier Intelligence, the leading AI rehabilitation solutions provider, and John Hopkins Aramco Healthcare, a subsidiary of Saudi Aramco and one of the leading healthcare providers in the Middle East, announced today the signing of a memorandum of understanding (MOU) at the second LEAP event in Riyadh.

The MOU outlines the collaboration between the two organisations to explore opportunities to integrate Fourier Intelligence’s cutting-edge AI technology into physical rehabilitation treatments at John Hopkins Aramco Healthcare facilities.

This collaboration will potentially allow John Hopkins Aramco Healthcare patients to benefit from Fourier Intelligence’s AI-powered rehabilitation technology, significantly enhancing the rehabilitation process and speeding up recovery. The technology will also allow real-time tracking and monitoring of patients’ progress and make data-driven recommendations for further treatment.

“We are thrilled to collaborate with John Hopkins Aramco Healthcare to bring our cutting-edge technology to the Middle East,” said Zhi Kang TAI, Commercial Director of Fourier Intelligence. “Our AI-powered rehabilitation solutions are changing the game in the physical rehabilitation industry. This collaboration will allow us to provide access to our innovative technology to more patients in need.”

“We are proud to collaborate with Fourier Intelligence to bring their innovative AI technology to our patients,” said Lamia Alzayer, Sr. Director, Specialised Therapy & Clinical Services of John Hopkins Aramco Healthcare. “This collaboration represents our commitment to providing the highest quality of care and utilising cutting-edge technology to improve patient outcomes.”

The MOU signing ceremony by Zhi Kang TAI, Commercial Director of Fourier Intelligence and Lamia Alzayer, Sr Director, Specialised Therapy & Clinical Services of John Hopkins Aramco Healthcare

The MOU signing ceremony was attended by senior executives from both organisations at the second edition of LEAP, attended by over 100,000 technology innovators and experts worldwide.

About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

About John Hopkins Aramco Healthcare:

Johns Hopkins Aramco Healthcare Company (JHAH) is the result of a joint venture between Saudi Aramco, a world leader in energy, and Johns Hopkins Medicine, one of the world’s leading academic health systems. This healthcare organisation is designed to drive and enhance the community’s well-being in an environment of growth and learning by providing innovative, integrated, patient-centred care to Saudi Aramco’s employees and healthcare beneficiaries.

For investor and media inquiries, please contact:

Sarah LIM, Assistant Director
Fourier Intelligence
Phone: +65-6911-6651
Email: sarah.lim@fftai.com

Fourier Intelligence Signs MoU with Bond University

Fourier Intelligence and Bond University embark on their journey to showcasing advancing technologies in medical robotics through significant steps.

Gold Coast, Australia, 15 February 2023 – Fourier Intelligence, a leading provider of rehabilitation solutions, and Bond University, Australia’s leading independent, not-for-profit university, signed a Memorandum of Understanding (MoU), marking the commencement of a significant partnership to optimise further and develop the implementation, integration, and adoption of rehabilitation technology.

Both parties agree on strengthening, promoting, and developing academic, cultural, and research cooperation.

Fourier Intelligence’s Co-Founder and Global CEO, Zen Koh; Dr Chen-Onn Leong, Manager of Scientific Research; Taya Hamilton, Clinical Consultant, commemorated this momentous occasion through a virtual ceremony alongside representatives from Bond University; Professor Wayne Hing, Head of Physiotherapy, Assistant Professor Philip Abery and Assistant Professor Elisa Canetti from Bond’s Faculty of Health Sciences & Medicine; and Andrew Pearce, Managing Director of AIMedical.

The collaboration between both parties hopes to bring advancements in rehabilitation technology to individuals across all stages of rehabilitation, ensuring access to the care and technology they need. The emergence of a new gait lab and upcoming research project exploring the integration of exoskeleton technology into the home and community settings at Bond University brings this possibility a step closer.

Zen Koh shared the importance and significance of this collaboration with Bond University, adding that ensuring continual growth, sustenance, and innovation is crucial. “We’re taking another step forward in bringing more partners and collaborators to journey with us from the clinical research and technology development front through partnership and bring us much closer to achieving our dreams of making the industry more consolidated and standardised, benefiting both our clinicians and patients.”

Professor Hing adds, “We’re excited for the growth opportunities based around the concept of rehabilitation returning to the community and being able to utilise medical robotics at home. Bond University’s new gait lab will allow laboratory-based research in our facilities. It ideally strategically transforms our approach from the lab into the homes and communities.”

About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

About Bond University 

Bond University is Australia’s leading independent, not-for-profit university, dedicated to a deliberately different, personalised approach to education. Bond’s Faculty of Health Sciences and Medicine is recognised for the excellence of its education and research in medical, health and sports sciences. The faculty is a national leader in teaching and producing work-ready graduates with the leadership skills to improve local, national, and global health and well-being. Bond offers a personalised education experience, and for the past sixteen consecutive years, the university has ranked No. 1 in Australia for student experience.  

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fftai.com

Fourier’s Global Standard Development Lead, Burkhard Zimmermann, elected Technical Project Lead for IEC SC62D, JWG36

Switzerland, 25th January 2023 – Fourier’s Global Standard Development Lead, Burkhard Zimmermann, has been elected Technical Project Lead for IEC SC62D JWG 36 (RACA Robot). Based in Switzerland, he will focus on advancing global standards implementation in medical robotics for rehabilitation.

Burkhard is the founding member of the International Industry Society in Advanced Rehabilitation Technology (IISART), an organisation dedicated to advancing modern healthcare technology to benefit the patient and the profession. Burkhard’s new role as Technical Project Lead for RACA Robot is vital for Fourier Intelligence’s positive support in international standards and other publications to support safety and performance for medical equipment and software systems.

Burkhard Zimmermann

JWG36 is an esteemed committee dedicated to continuously improving the standards applicable to the general requirements for basic safety and essential performance of medical robots for rehabilitation, compensation or alleviation of disease, injury or disability.

“Medical robotics have come a long way from its origins. There have been leaps and bounds in terms of the technology available for a wide range of procedures, increasing efficiencies, productivity, safety and quality,” said Zen Koh, incoming President of IISART, Co-Founder and Global CEO of Fourier Intelligence.

“As standards emerge and evolve to ensure the safety and performance of these cutting-edge products, it is our responsibility as innovation leaders to stay current on the requirements in ensuring compliance when bringing such devices into the market. Burkhard’s new role at IEC will support Fourier’s efforts in delivering top-quality products that are safe and efficient.”

About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fftai.com

Fourier Intelligence Joins Leading Trade Association, Electrosuisse

Fourier Intelligence is now a member of Electrosuisse, a global trade association for electrical, energy, and information technology

SWITZERLAND, 21 December 2022 – Leading health technology group Fourier Intelligence is happy to announce joining Electrosuisse as a member. Electrosuisse has focused on promoting safe, economic, and environmentally friendly electricity generation and usage for the past 130 years.

Founded in 1889, Electrosuisse has become a global trade association for electrical, energy, information, and communication technology. As a specialist organisation with over 2000 members, it has also played a crucial role in disseminating knowledge and interest groups within the field with information on international standardisation and certification bodies.

Electrosuisse is a member of the International Electrotechnical Commission (IEC) and represents Switzerland. The organisation offers training, advice, inspection, testing and certification to ensure environmental governance is met.

As a health technology group, Fourier Intelligence is known to have an extensive portfolio of solutions to offer. Developing such advanced technology takes considerable energy and requires plenty of testing for medical devices. Being a member of Electrosuisse further signifies its mission to promote economical and safe devices to its clients and partners.

“We are pleased and look forward to being a part of Electrosuisse. As the standardisation and certification of each country evolve, it is crucial to stay connected to support one another in this matter,” mentioned Zen Koh, Co-Founder and Global CEO of Fourier Intelligence Group.

“The association’s vision aligns with Fourier’s goal of promoting safe and economic health technology to our network. We believe that together with the vast network of Electrosuisse, we can widely influence and promote safer technology by contributing our expertise to international standardisation activities.”   

About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fftai.com

Fourier Intelligence strengthens partnership by signing MOU with Thor Assistive Technologies

Fourier Intelligence signs a Memorandum of Understanding with United Kingdom distributor and sales partner Thor Assistive Technologies to extend the reach of products to the Europe Market

UNITED KINGDOM, 30 November 2022 – Fourier Intelligence and Thor Assistive Technologies signed a Memorandum of Understanding (MOU) witnessed by the British Consulate online via Zoom on 23 November 2022 at UK MedTech Forum in China International Medical Equipment Fair (CMEF).

The CMEF represents an online international medical equipment exhibition to connect global licensed medical equipment distributors, resellers, manufacturers, health professionals, and agencies. The event started with Matt Moddy, British Consul-General in Guangzhou, providing the opening remarks, followed by various speeches by Dr. Linda Magee (Health Innovation and NGS Specialist, Department for International Trade) and Paul Benton (Managing director International, Association of British Health Industries).

The tech giant Fourier Intelligence represents one of the four companies selected to participate in the United Kingdom (UK) Med Tech Forum MOU signing to represent the partnership between China and the UK.

The MoU Signing Ceremony then began alongside the DIT Digital Platform Launching. The signatory included Zen Koh, Co-Founder and Global CEO of Fourier Intelligence, and Neil Shorthouse, Finance Director of Thor Assistive Technologies. Furthermore, the signing event included witnesses such as Owen Teoh, General Manager of Fourier Intelligence, Chris Sloan, Company Director of Thor Assistive Technologies, and the British Embassy and Consulate SLTs.

The partnership allows Fourier Intelligence to distribute in the UK, spreading their rehabilitation solutions globally and leveraging the European research and market. At the same time, Thor Assistive Technologies gains to provide a broader range of technology solutions to the UK health sector, making their rehabilitation solutions more diverse and comprehensive to cater to public needs.

About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fftai.com

University of Melbourne-Fourier Intelligence Joint Laboratory Co-Director Honoured with IEEE Fellow Distinction

Melbourne, 24th November 2022 – The Institute of Electrical and Electronics Engineers (IEEE) has just announced its 2023 Fellows. Professor Ying Tan, Co-Director of the University of Melbourne-Fourier Intelligence Robotics Joint Laboratory, was amongst 319 scientists that were selected. This recognition is given to eminent scholars and scientists who have made substantial contributions to research, teaching, or scholarly efforts. The award recognises Professor Ying Tan’s achievements in rehabilitation robotics.

The IEEE is the world’s largest international professional association for advancing technology for humanity’s benefit. It has remained an essential organisation to technical professionals universally and is recognised for the contributions of technology and improving global conditions. Since its inception in 1963, it has gained over 409,000 members across 160 countries.

Professor Ying Tan obtained the highest grade of membership – the IEEE Fellow. This demonstrates a distinction for the profession that required peers’ nominations and approval by the IEEE Board of Directors. An average of 300 members are selected each year, and the number of elected members shall not exceed 1% of the current year’s total number of IEEE members.

In 2004, Professor Ying Tan joined the Department of Electrical and Electronic Engineering at the University of Melbourne. She has since demonstrated significant contributions to the advancement of technology, leading to over 100 published papers in journals and conferences and attracting more than 7 million Australian dollars in research funding.

On top of being the IEEE Fellow, Professor Ying Tan was awarded the Australian Postdoctoral Fellow and Future Fellow in 2006 and 2014, respectively, by the Australian Research Council. Since 2018, she has been a co-director of the successful industry-academic joint lab with Softbank-backed Fourier Intelligence in advancing rehabilitation robotics technology.

Figure 1: Professor Ying Tan is working with Dr Vincent Crocher on the first prototype of the ArmMotus™ EMU

Her current work with Fourier Intelligence focuses on technologies to assist with movement impairments, especially for those with neurological conditions. Her team in Melbourne carries out fundamental and translational research for rehabilitation robotics. The ArmMotus™ EMU was a successful commercialisation project from the lab. 

Figure 2: The finalised ArmMotus™ EMU from the University of Melbourne-Fourier Robotics Joint Laboratory

“We are pleased to congratulate Professor Ying Tan on her recent appointment as a Fellow by the IEEE,” said Zen Koh, Co-Founder and Global CEO of Fourier Intelligence, Co-Director of the University of Melbourne-Fourier Robotics Joint Laboratory. “Ying has led, as co-director, research that resulted in successful technology transfer. The award-winning ArmMotus EMU is just one such example. She is a well-deserving recipient for her impactful contributions to rehabilitation robotics, and we look forward to working with her in future joint efforts.”

About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fftai.com

Fourier Intelligence is part of the World’s Largest Medical Trade Fair

Fourier Intelligence showcases award-winning technology at International MEDICA-TradeFair 2022 in Düsseldorf, Germany

DÜSSELDORF, GERMANY, 18 November 2022 – Fourier Intelligence makes its mark in Germany as part of the several thousand exhibition booths from more than 50 countries at MEDICA-TradeFair 2022, from 14 to 17 November 2022. For more than 40 years, MEDICA-TradeFair has been purposed to showcase the leading innovations and businesses in medical technology, products, devices, and instruments. The event was attended by thousands of national and international leaders, health professionals and decision-makers.

As one of the forerunners in rehabilitation technology, Fourier Intelligence was part of the physiotherapy and orthopaedic technology exhibition hall showcasing various award-winning rehabilitation technology and solutions. In addition, the technology unicorn conducted daily demos of some of its featured products, such as the ArmMotus™ EMU and M2 Pro, highlighting its fun, immersive, interactive gaming software. It also doubles up as group therapy through its Wi-Fi connection, allowing multiple patients to play against one another in real time.

The ExoMotus™ M4 featured is an advanced exoskeleton that allows for the safe mobilisation of the lower limbs and gait training. Lastly, BalanceMotus™ KINE-SIM was featured as the world’s first balance and gait exercise equipment combining motorised force plates, simultaneously tracking and training one’s balance.

The fair also provided the rehabilitation robotics leaders with a platform to promote RehabHub™, which represents a one-stop rehabilitation solution that gives a variety of rehabilitation robotics with online interconnectivity.

As forerunners in rehabilitation technology, it’s no surprise that Fourier Intelligence technology solutions represent MEDICA-TradeFair 2022’s theme of “where healthcare is going” by increasing the efficiency of rehabilitation, reducing the strain of health professionals, while also making rehabilitation enjoyable for its users.


About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fftai.com

Fourier Intelligence Signs MoU with the University of New South Wales

Another significant step in the advancement of medical technologies with a partnership between Fourier Intelligence and UNSW Sydney

New South Wales, 16 November 2022 – A Memorandum of Understanding (MoU) has been agreed upon and signed, promoting cutting-edge robotics that can impact lives worldwide.

Fourier Intelligence strives to consolidate the healthcare technology industry by collaborating with key experts across the globe. The team has formed many fundamental partnerships with researchers and clinicians worldwide.

Its MoU with the University of New South Wales (UNSW), Sydney is a pivotal point for the group as it can propel the advancement of rehabilitation technologies to reach a higher potential.

A virtual signing ceremony was held to commemorate the partnership between Fourier intelligence and UNSW. The virtual ceremony was attended by Zen Koh, Co-Founder and Global CEO of Fourier Intelligence; Chen Onn Leong, Manager for Scientific Research; Taya Hamilton, Clinical Consultant, Oceanic Region from Fourier Intelligence; Professor Nigel Lovell, Scientia Professor, Head of the Graduate School of Biomedical Engineering (GSBmE) and Director of Tyree Foundation Institute of Health Engineering (IHealthE), and Dr Thanh Nho Do, Scientia Senior Lecturer from UNSW Sydney.

From Top Left: Prof. Nigel Lovell, Zen Koh; From Bottom Left: Dr Thanh Nho Do, Chen Onn Leong, Taya Hamilton

The UNSW Medical Robotics Lab and other members from Prof. Lovell’s teams are developing state-of-the-art bio-inspired soft robotics, smart textiles, bionic systems, and telehealth, garnering attention from researchers and media worldwide.

“We believe collaboration lies at the heart of unlocking the full potential of this industry,” says Zen Koh, Co-Founder and Global CEO of Fourier Intelligence.

“We are proud to play a key role in driving this rapidly growing field. We are committed to working with Prof. Lovell and Dr Do and their teams to elevate patient experience and optimise the performance of the technologies to deliver positive impact.”

Prof. Lovell says: “This MoU will strengthen the capabilities for research translation within UNSW Engineering, Tyree IHealthE, and GSBmE to create innovative technologies around bionics and bio-robotics that are useful and impactful.”

Dr Do adds: “The forthcoming collaborative projects with Fourier Intelligence will enable us to bring new knowledge creation and scientific inventions from the research laboratory to marketplace.” By joining forces with the talent within GSBME and IHealthE, Fourier Intelligence will be able to investigate and explore how its advanced artificial intelligence technology and control systems can be integrated into the existing clinical devices. The aim is to provide technology that can be customised and individualised to provide effective and efficient therapy for patients.


About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into developing exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

About the University of New South Wales

UNSW’s strategic priorities actively address the challenges we face today – from climate change and renewable energies to lifesaving medical treatments and breakthrough technologies. We aim to make an impact on people’s lives around the world. 

In 2020, UNSW evolved its motto to “Scientia corde mente et manu” – Knowledge by Heart, Mind and Hand. This is more than just a slogan of renewed values and aspirations. It captures the fact that we serve a higher purpose, and are committed to serving society through knowledge sharing and new discovery.

https://www.unsw.edu.au/about-us/our-story

About Tyree IHealthE

Our healthcare system needs to meet the demands of the 21st century. Tyree IHealthE exists to solve our most critical challenges – and improve health outcomes, locally and globally. Tyree IHealthE harnesses the considerable capabilities of UNSW Engineering and UNSW Medicine and Health. Powered by collaboration, Tyree IHealthE is an engine of discovery and research translation.  We are currently establishing the Sydney Consortium for Improving Medicine with Innovation and Technology (SCIMIT). A highly successful initiative, originating in Boston, that brings together clinicians, technologists and industry, SCIMIT will identify unmet healthcare needs and provide a platform for the development of effective new medical technologies.

The uptake of these innovations into mainstream clinical practice is fast-tracked by our strong healthcare partnerships.

https://www.ihealthe.unsw.edu.au/

About UNSW Medical Robotics Lab

In the UNSW Medical Robotics Lab, our research is primarily in the development of Advanced Surgical Systems, Soft Robotics, Wearable Haptics, Soft Exoskeletons, Artificial Organs, Programmable Textile Muscles, Nonlinear Control, and other Medical Devices that contribute to enhance the human quality of life. Our lab is located at Level 1, E26 Biological Sciences Souththe Graduate School of Biomedical Engineering, Faculty of Engineering, UNSW, Sydney, Australia. The lab is a place where engineers, neuroscientists, and medical doctors work together to create advanced medical systems, wearable haptic devices, and soft robotic technologies. We design, fabricate, and control surgical robots, soft robotics, haptic devices, and advanced mechatronic systems in medicine more accurate, non-invasive, effective, and at low cost. We also patent our innovative ideas that enable us to transform them from the laboratory to commercial products. Our current major projects include flexible and miniature surgical systems for gastrointestinal cancer and cardiovascular disease treatments, soft robotics, wearable haptics, soft assistive devices, artificial organs, programmable textile muscles, and advanced control systems.

https://www.medicalrobotics-lab.com/

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fftai.com

Fourier Intelligence Announces World-Class Scientific Advisory Board

Fourier Intelligence, the global leader in rehab tech, announces the launch of its scientific advisory board to promote innovation and growth.

SINGAPORE, 31 October 2022 – Fourier Intelligence, a leading rehabilitation technology company, announced today that it had formed a world-class scientific advisory board to support its innovation and growth.

The board will support Fourier’s continued innovation and growth as a company by providing strategic guidance on emerging technologies and ensuring that the company can meet the growing demands for its products. The advisory comprises top scientists and academics with experience in rehabilitation medicine and technology. They will work closely with Fourier’s leadership team to ensure that the company maintains its position as an industry leader in healthcare technology.

The scientific advisory board will include some of the most prestigious names in medicine and science, including:

Top Row (Left to Right): Professor Jose L. Pons, Professor Dario Farina, Professor Milos R. Popovic, Professor Robert Riener. Bottom Row (Left to Right): Professor Denny Oetomo, Dr Manuel Murie Fernández, Dr Marco Hutter, Dr Arno Stienen.

Professor Jose L. Pons; Professor Pons is the Scientific Chair of the Legs + Walking Lab of the Shirley Ryan AbilityLab. He is the Director of the Neural Rehabilitation Group in the Department of Translational Neuroscience, CSIC, Spain and co-founder and Vice-President of MotusAcademy. He has coordinated over 15 EU and international research projects with over 400 published peer-reviewed journal articles. Professor Pons is a fellow at the American Institute of Medical and Biological Engineering (AIMBE). With his expertise, he is an associate editor for several journals in neuroprosthesis and neural engineering.

Professor Dario Farina; Professor Farina is the chair of Neurorehabilitation Engineering at the Imperial College of London. In 2018, he obtained an Honorary Doctorate in Medicine from Aalborg University in Denmark. He has received over 10 million Euros of research funding from the European Research Council. Professor Farina founded and directed the Institute of Neurorehabilitation Systems, University Medical Center Gottingen, Germany. He was President of the International Society of Electrophysiology and Kinesiology (ISEK) between 2012 and 2013.

Professor Milos R. Popovic; Professor Popovic is the Director of the KITE Research Institute with the University Health Network (UHN) in Toronto. He was responsible for establishing the Centre for Research in Advances Implant Applications (CRANIA) at the University of Toronto and the UHN Network. In 2004, he co-founded and was co-chair of the Canadian National Spinal Cord Injury Conference. Professor Popovic won first place and the Best Intellectual Property Award at the annual TIEQuest Business Venture for his company, MyndTec Inc.

Professor Robert Riener; Professor Riener is the head of the Sensory Motor Systems Lab at ETH Zürich and a professor of rehabilitation robotics ad the Medical Faculty, University of Zurich, Switzerland. He is the founder and President of CYBATHLON, the world’s first international competition for people with physical disabilities using bionic technology. He is also the current President of the International Consortium of Rehabilitation Robotics (ICORR) and co-founder and President of MotusAcademy. Professor Riener has published over 400 peer-reviewed journals and 24 patents. He has co-directed the National Centre of Competence in Research (NCCR) of Robotics and was or still is a guest professor at several prestigious universities, including the University of Southern California, the Scuola Superiore Sant’Anna and the Shanghai Jiao Tong University.

Professor Denny Oetomo; Professor Oetomo is the Director of the University of Melbourne – Fourier Intelligence Joint Research Laboratory. He is the associate editor for various journals, including the IEEE Robotics and Automation Letters, IEEE Transactions on Mechatronics, ASME Journal of Mechanisms and Robotics, and Mechatronics (Elsevier). He has received and overseen 7 Australian Research Council projects in robotics and human-robot interaction. Professor Oetomo is the lead behind the successful technology transfer of the award-winning upper limb assistive robot, the ArmMotusTM EMU, with Fourier Intelligence. The robot received the 2022 Red Dot Award, the iF Design Award, the Medical Design Excellence Award, and the “G-Mark” from the Good Design Award.

Dr Manuel Murie Fernández; Dr Fernández is the Medical Director of the Neurorehabilitation Unit of the Hospital ICOT Ciudad de Telde in Spain. He is the head of the neurology service at the San Miguel Clinic, Pamplona, and an Associate Professor at the Public University of Navarra. He completed his fellowship in neurorehabilitation from the University of Western Ontario and has been a mentor for young neurologists in the World Society for Neurorehabilitation. In 2017, Dr Fernández was listed in the Choiseul 100 España as one of the Economic Leaders for Tomorrow. With his expertise, he is sitting on the European Academy of Neurology scientific panel and the editorial board member of Neurología Journal.

Dr Marco Hutter; Dr Hutter is the Director of the Centre for Robotics at ETH Zürich. He is the co-founder of multiple companies, including a board member of ANYbotics AG and Gravis Robotics AG, where he is also CEO. Dr Hutter has won several awards and grants, such as the Branco Weiss Fellowship, ETH medal, IEEE/RAS Early Career Award and ERC Starting Grant. He is the associate editor in a few robotics and automation journals.

Dr Arno Stienen; Dr Stienen is an Associate Professor at the TU Delft, The Netherlands focusing on human augmentation. He was previously the VP of Product Management at DIH Technologies, and Director at Motek Medical B.V. Dr Stienen was the program director of the Professional Doctorate in Engineering in Robotics at the University of Twente, where he obtained his PhD. He publishes research on rehabilitation robotics, human-machine interaction, exoskeletons, and robotics in unstructured and compliant environments.

“We are thrilled to welcome such a distinguished group of experts into our team to support our product development efforts,” said Zen Koh, Co-Founder and Global CEO of Fourier Intelligence. “They bring years of experience in some of our most important areas of innovation, including rehabilitation, machine learning, AI, virtual reality training systems, robotics, and more. Their expertise and experience will help us make sure we are always on track with our goals.”

The board will support the company’s growth and innovation by providing feedback, advice, and insight into product development.

For investor and media inquiries, please contact:
Sarah Lim,
Assistant Director, Support Services at Fourier Intelligence,
Fourier Intelligence
Phone: +65 6911 6651
Email: marketing.globalhq@fftai.com